Sweetgreen, the $1.78 billion salad chain founded in a Georgetown dorm room, is set to IPO Sweetgreen’s IPO announcement came after years of steady growth and $670 million in venture capital raised, a milestone for the salad chain unicorn. Ivan De Luce 11.18.21 3:00 PM Markets
NerdWallet’s IPO could make it worth $5 billion — or more than the value of Vice and BuzzFeed combined NerdWallet, positioned to become one of the most valuable media companies, was built by founder Tim Chen from home after he was laid off. Ivan De Luce 10.21.21 8:53 PM Markets
Restaurants are still serving up IPOs, and Dutch Bros and First Watch are next on the menu Dutch Bros had a stellar opening on the NYSE. While First Watch hasn’t gone public yet, the company hopes to expand to 2,200 locations after its IPO. Ivan De Luce 9.17.21 2:34 PM Markets
A brief history of why Martin Shkreli got banned from Twitter The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.23.22 12:25 AM Outcasts
Here comes a wave of space companies blasting off for the public markets — and the vehicle of choice is a SPAC Space startups like Voyager and Virgin Orbit are are among the players preparing to make their public debuts, while companies like Rocket Lab and Momentus are already trading. Ivan De Luce 9.16.21 3:42 PM Markets
How Olaplex grew from a cult haircare brand into a beauty staple seeking a $1.5 billion IPO Founder Dean Christal nearly gave up on finding the right formula for his product back in 2014. Now, Olaplex is Sephora’s top haircare brand ahead of its public debut. Ivan De Luce 9.1.21 8:15 PM Markets
Leafly is the latest cannabis company to go public, in a $532 million SPAC deal Weed giant Leafly will be joining several other prominent cannabis companies that have made their public debuts this year. Ivan De Luce 8.11.21 8:55 PM Markets
"Repulsive," "reptilian," "diseased": What John D. Rockefeller had in common with Martin Shkreli The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.20.22 5:13 PM Features